Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25138 | Gridegalutamide (Synonyms: BMS-986365 ) | 2446928-30-7 | ≧98.0% |  |
| Gridegalutamide, also known as BMS-986365 and CC-94676, is an orally bioavailable and | ||||
| 25118 | Givinostat HCl hydrate | 732302-99-7 | 98% Min. |  |
| Givinostat hydrochloride is a novel histone deacetylase inhibitor with potential anti | ||||
| 25105 | Glecirasib | 2658538-04-4 | 98% Min. |  |
| 25082 | GSK-2330672 | 1345982-69-5 | 98% Min. |  |
| GSK-2330672, also known as linerixibat, is highly potent, nonabsorbable apical sodium | ||||
| 25062 | GP130 modulator-1 | 2375779-31-8 | ≧98.0% |  |
| GP130 modulator-1 (compound A33) is agp130signaling pathway modulator. GP130 modulato | ||||
| 24131 | GSK1059865 | 1191044-58-2 | 98% Min. |  |
| GSK1059865 is a potent orexin 1 receptor antagonist. | ||||
| 24076 | G-5758 | 2413455-99-7 | 98% Min. |  |
| 24031 | GW-280264 ( GW-280264X ) | 866924-39-2 | ≧98.0% |  |
| GW-280264 ( GW-280264X ) is the mixedADAM10/TACE (ADAM17) metalloproteinasesinhibitor. | ||||
| 24028 | Golidocitinib ( AZD-4205 ) | 2091134-68-6 | ≧98.0% | _2091134-68-6.png) |
| Golidocitinib (AZD-4205) is an oral JAK1 selective kinase inhibitor. | ||||
| 20672 | Glecirasib | 2657613-87-9 | 98% Min. |  |
| 20630 | Ganaxolone | 38398-32-2 | 98% Min. |  |
| Ganaxolone, also known as CCD 1042 and C1042, is a CNS-selective GABAA modulator that | ||||
| 20589 | GNE-7883 | 2648450-42-2 | 98% Min. |  |
| GNE-7883 is a pan-TEAD inhibitor. | ||||
| 230401 | Glycerol phenylbutyrate ( HPN-100 ) | 611168-24-2 | ≧98.0% | .png) |
| Glycerol phenylbutyrate, also known as HPN-100, is under trials in the treatment of c | ||||
| 171459 | GSK 525762A | 1260907-17-2 | 98% Min. |  |
| 20375 | GSK5182 | 877387-37-6 (free base) | 98% Min. |  |
| GSK5182 is a specific inverse agonist for estrogen-related receptor γ. | ||||
| L20356 | GF-109203X | 133052-90-1 | 98% Min. |  |
| GF-109203X is a potent and highly selective PCK inhibitor, which inhibits PKC isozyme | ||||
| L20342 | GDC-046 | 1258292-64-6 | 98% Min. |  |
| GDC-046 is a potent, selective, and orally bioavailable TYK2 inhibitor for TYK2, JAK1 | ||||
| c20341 | GDC-0214 | 1831144-46-7 | 98% Min. |  |
| iJak-381 is a highly potent, selective, and inhalable Janus kinase-1 (JAK-1) inhibito | ||||
| L20339 | GYY4137 | 106740-09-4 | 98% Min. |  |
| GYY4137 is a novel water-soluble and slow releasing H2S donor. Hydrogen sulfide (H2S) | ||||
| L20335 | GDC-0077 | 2060571-02-8 | 98% Min. |  |
| Inavolisib, also known as GDC-0077, is a potent and selective PI3K inhibitor. GDC-007 | ||||
| 20304 | Gloxazone | 2507-91-7 | 98% Min. |  |
| Gloxazone is an effective but toxic anaplasmacide. | ||||
| 20295 | Glymidine sodium | 3459-20-9 | 98% Min. |  |
| Glymidine sodium is a sulfonamide hypoglycemic agent which stimulates insulin secreti | ||||
| 20292 | Golgicide A | 1139889-93-2 | 98% Min. |  |
| Golgicide A is a Potent, selective and reversible inhibitor of GBF1 ArfGEF. Golgicide | ||||
| 20283 | GDC-0077 | 98% Min. |  | |
| GDC-0077 is a potent and selective PI3K inhibitor. GDC-0077 blocks an enzyme involved | ||||
| 20275 | GS 0573 ( PMEDAP ) | 113852-41-8 | 98% Min. |  |
| GS 0573 is an antiviral compound that has been studied for potential treatment of Fel | ||||
| 20263 | Giredestrant tartrate | 2407529-33-1 | ≧98.0% |  |
| Giredestrant tartrate (GDC-9545 tartrate), a non-steroidal ER ligand, is an orally ac | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 21226 | GNF-PF-3777 | 77603-42-0 | 98% Min. |  |
| GNF-PF-3777 is a derivative of tryptanthrin. | ||||
| 20111801 | GSK484 HCl | 1652591-81-5 | 98% Min. |  |
| GSK484 is a potent PAD-4 inhibitor (Protein-arginine deiminase type-4). GSK484 potent | ||||
| 2071802 | GCN2iB | 2183470-12-2 | 98% |  |
| GCN2iB is an ATP-competitive GCN2 inhibitory compound with a better pharmacokinetic p | ||||